loader
Please Wait
Applying Filters...

Approved Drug Products containing Prestwick3_001069 listed with Health Canada. Original Data : Health Canada Website

Menu
$ API Ref.Price (USD/KG) : 47Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5ABBVIE CORPORATION

02 3AVIR PHARMA INC.

03 5FERRING INC

04 1TAKEDA CANADA INC

05 1TEVA CANADA LIMITED

06 2TILLOTTS PHARMA AG

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : SALOFALK

Dosage Form : SUSPENSION

Dosage Strength : 4G/60G

Packaging : 7

Approval Date :

Application Number : 2112809

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner

02

arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : SALOFALK

Dosage Form : SUSPENSION

Dosage Strength : 2G/60G

Packaging : 7

Approval Date :

Application Number : 2112795

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner

03

arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : SALOFALK

Dosage Form : SUPPOSITORY

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number : 2112760

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner

04

arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : SALOFALK

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number : 2112787

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner

05

arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : SALOFALK

Dosage Form : SUPPOSITORY

Dosage Strength : 1000MG

Packaging :

Approval Date :

Application Number : 2242146

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner

06

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : PENTASA

Dosage Form : SUPPOSITORY

Dosage Strength : 1G

Packaging : 30

Approval Date :

Application Number : 2153564

Regulatory Info : Prescription

Registration Country : Canada

blank

07

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : PENTASA

Dosage Form : SUSPENSION

Dosage Strength : 4G/100ML

Packaging : 100ML

Approval Date :

Application Number : 2153556

Regulatory Info : Prescription

Registration Country : Canada

blank

08

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : PENTASA

Dosage Form : SUSPENSION

Dosage Strength : 1G/100ML

Packaging : 100ML

Approval Date :

Application Number : 2153521

Regulatory Info : Prescription

Registration Country : Canada

blank

09

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : PENTASA

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 500MG

Packaging : 240

Approval Date :

Application Number : 2099683

Regulatory Info : Prescription

Registration Country : Canada

blank

10

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

MESALAZINE

Brand Name : TEVA-5 ASA

Dosage Form : TABLET (ENTERIC-COATED)

Dosage Strength : 400MG

Packaging : 100/500/1000

Approval Date :

Application Number : 2171929

Regulatory Info : Prescription

Registration Country : Canada

blank